Association of adverse childhood experiences and neurodevelopmental disorders in people with fetal alcohol spectrum disorders (FASD) and non-FASD controls
Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we...
Saved in:
Published in | BMC pediatrics Vol. 19; no. 1; pp. 498 - 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
16.12.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls.
A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups.
The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094).
Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. |
---|---|
AbstractList | Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls.BACKGROUNDFetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls.A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups.METHODSA cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups.The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094).RESULTSThe review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094).Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.CONCLUSIONSBoth FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. Methods A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. Results The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Conclusions: Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. Keywords: Children, Adverse childhood experiences, Fetal alcohol spectrum disorders, Comorbidity, Child protection, Criminal justice, Special education, Outcomes, Controls Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. Methods A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient’s chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. Results The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Conclusions: Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. Abstract Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. Methods A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient’s chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. Results The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Conclusions: Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. |
ArticleNumber | 498 |
Audience | Academic |
Author | Kambeitz, Cassondra Popova, Svetlana Klug, Marilyn G. Greenmyer, Jacob Burd, Larry |
Author_xml | – sequence: 1 givenname: Cassondra surname: Kambeitz fullname: Kambeitz, Cassondra – sequence: 2 givenname: Marilyn G. surname: Klug fullname: Klug, Marilyn G. – sequence: 3 givenname: Jacob surname: Greenmyer fullname: Greenmyer, Jacob – sequence: 4 givenname: Svetlana surname: Popova fullname: Popova, Svetlana – sequence: 5 givenname: Larry orcidid: 0000-0001-7199-2711 surname: Burd fullname: Burd, Larry |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31842817$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstu1DAYhSNURC_wAGxQJCRUFil2nPiyQRoVCpUqsQDWlmP_aVx57GAnA7wKT4vTaWGmAnnh23eO7d_nuDjwwUNRPMfoDGNO3yRcc84qhEWFOeMVf1Qc4Ybhqm4IPtgZHxbHKd0ghBlv6JPikGDe1Byzo-LXKqWgrZps8GXoS2U2EBOUerDODCGYEn6MEC14DalU3pQe5hgMbMCFcQ1-Uq40NoVosq60vhwhjA7K73Yayh6WbeV0GIIr0wh6ivN6hz-9WH1-93rrG3y1zEod_BSDS0-Lx71yCZ7d9SfF14v3X84_VlefPlyer64q3Qo8VQppVTMFhNeo7SnrkCCCaCpqjohhuu46ihtaC9x3WBhMWmJI3YNWQBngjpwUl1tfE9SNHKNdq_hTBmXl7UKI11LFyWoHsqVE6Jox3DSsMQ0Wohc9pZ1Bfcs0NNnr7dZrnLs1GJ3rE5XbM93f8XaQ12EjqcC1aGg2OL0ziOHbDGmSa5s0OKc8hDnJmtRMkLbNjzwpXj5Ab8IcfS7VQvEWZ4r-pa5VfoD1fcjn6sVUrihGBAlGUabO_kHlZmBt84dAb_P6nuDVjmAA5aYhBTcvOUr74IvdivwpxX0EM8C2gI4hpQi91Ha6zWO-gnUSI7mEXW7DLnPY5RJ2ybMSP1Dem_9f8xsrlQC- |
CitedBy_id | crossref_primary_10_3389_fnint_2023_1104788 crossref_primary_10_1016_j_pediatrneurol_2024_04_023 crossref_primary_10_1097_AOG_0000000000004632 crossref_primary_10_1016_j_earlhumdev_2020_105119 crossref_primary_10_1080_19315864_2023_2285040 crossref_primary_10_1016_j_drugalcdep_2020_108412 crossref_primary_10_1016_j_ridd_2023_104481 crossref_primary_10_4236_ojped_2021_114054 crossref_primary_10_1016_j_yfrne_2023_101103 crossref_primary_10_1111_cch_12817 crossref_primary_10_3390_ijerph192315663 crossref_primary_10_1016_j_cpr_2022_102155 crossref_primary_10_1007_s11920_020_01193_w crossref_primary_10_1016_S2352_4642_24_00331_6 crossref_primary_10_1007_s11469_021_00652_6 crossref_primary_10_1111_acer_70039 crossref_primary_10_1016_j_brainres_2020_147128 crossref_primary_10_3390_nu16111655 crossref_primary_10_1080_09297049_2021_2023122 crossref_primary_10_1016_j_ntt_2025_107436 crossref_primary_10_3390_ijerph20176706 crossref_primary_10_1007_s40474_021_00241_1 crossref_primary_10_1016_j_neuro_2021_08_013 crossref_primary_10_3389_fnbeh_2021_786234 crossref_primary_10_3389_fnins_2023_1182635 crossref_primary_10_1111_acer_15394 crossref_primary_10_3109_13668250_2025_2449677 crossref_primary_10_1111_acer_15191 crossref_primary_10_1177_14550725221110190 crossref_primary_10_3390_ijerph16203978 crossref_primary_10_1111_acer_14934 crossref_primary_10_3389_fnbeh_2025_1501937 crossref_primary_10_1016_j_chiabu_2023_106594 crossref_primary_10_3389_fnmol_2021_671891 crossref_primary_10_1016_S2352_4642_24_00188_3 crossref_primary_10_1177_0040059920977887 crossref_primary_10_3389_adar_2023_10877 crossref_primary_10_1080_13218719_2022_2059028 crossref_primary_10_3389_fped_2023_1146149 crossref_primary_10_1016_j_childyouth_2023_107192 crossref_primary_10_1002_bsl_2540 crossref_primary_10_1016_j_fsiml_2022_100109 crossref_primary_10_3390_disabilities4020022 crossref_primary_10_3390_jcm13061627 crossref_primary_10_1007_s10989_021_10173_4 crossref_primary_10_3389_fpsyg_2021_778471 crossref_primary_10_1016_j_ridd_2023_104479 crossref_primary_10_1186_s12887_022_03654_y crossref_primary_10_3390_healthcare10010084 crossref_primary_10_1016_j_ridd_2023_104553 crossref_primary_10_1080_14999013_2020_1852342 crossref_primary_10_3390_ijerph19137744 crossref_primary_10_1016_j_childyouth_2023_107239 crossref_primary_10_23736_S2724_5276_24_07365_8 crossref_primary_10_1038_s41598_022_26590_4 crossref_primary_10_1111_acer_14761 crossref_primary_10_1111_acer_15212 crossref_primary_10_1038_s41572_023_00420_x crossref_primary_10_1016_j_chiabu_2020_104888 crossref_primary_10_1016_j_ssmph_2020_100625 crossref_primary_10_1111_acer_15010 crossref_primary_10_1111_1460_6984_12644 crossref_primary_10_3390_children11010005 |
Cites_doi | 10.1016/j.ijlp.2017.12.008 10.1097/ADM.0000000000000438 10.1016/S0091-7435(03)00123-3 10.1097/DBP.0000000000000440 10.1080/19315864.2014.930549 10.1111/acer.13032 10.1176/appi.books.9780890425596 10.1542/peds.2015-4268L 10.1016/S0140-6736(15)01346-X 10.1016/j.alcohol.2009.08.010 10.1111/dmcn.12029 10.1016/j.amepre.2007.01.005 10.1016/j.whi.2015.06.007 10.1542/peds.2014-2171 10.1016/j.ntt.2003.07.014 10.1542/peds.2013-0066 10.1053/scnp.2000.6729 10.1016/S0749-3797(98)00017-8 10.1111/add.14598 10.1016/j.ntt.2003.07.015 10.15585/mmwr.mm6437a3 10.1503/cmaj.141593 10.1542/peds.108.2.e34 10.2174/1573404813666170418114243 10.1080/13556210410001717088 10.4236/ojped.2014.41003 10.1097/PSY.0b013e3181907888 10.3109/09638237.2011.577113 10.1016/j.drugalcdep.2015.08.006 10.1097/DBP.0000000000000523 10.1016/S0140-6736(15)01345-8 10.1515/IJDHD.2007.6.4.383 10.1002/ddrr.74 10.1007/978-1-4757-5217-5 10.1080/21622965.2013.877392 10.1080/23311908.2016.1214213 10.7895/ijadr.v2i3.173 10.1016/j.alcohol.2018.06.002 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12887-019-1878-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2431 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_5639c27714474d4199f9f66bd0f57ce4 PMC6912946 A610309760 31842817 10_1186_s12887_019_1878_8 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c591t-a0ca27ae38205f67b09393c692803d7c2bb6146291fb19d1353d32fecae67e1b3 |
IEDL.DBID | M48 |
ISSN | 1471-2431 |
IngestDate | Wed Aug 27 01:31:03 EDT 2025 Thu Aug 21 13:38:06 EDT 2025 Mon Jul 21 11:52:58 EDT 2025 Fri Jul 25 22:57:22 EDT 2025 Tue Jun 17 21:46:32 EDT 2025 Tue Jun 10 20:50:01 EDT 2025 Thu May 22 21:22:20 EDT 2025 Thu Apr 03 07:04:44 EDT 2025 Thu Apr 24 23:11:51 EDT 2025 Tue Jul 01 01:20:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Child protection Fetal alcohol spectrum disorders Comorbidity Criminal justice Controls Children Adverse childhood experiences Special education Outcomes |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c591t-a0ca27ae38205f67b09393c692803d7c2bb6146291fb19d1353d32fecae67e1b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7199-2711 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12887-019-1878-8 |
PMID | 31842817 |
PQID | 2328515506 |
PQPubID | 42847 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5639c27714474d4199f9f66bd0f57ce4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912946 proquest_miscellaneous_2327935509 proquest_journals_2328515506 gale_infotracmisc_A610309760 gale_infotracacademiconefile_A610309760 gale_healthsolutions_A610309760 pubmed_primary_31842817 crossref_citationtrail_10_1186_s12887_019_1878_8 crossref_primary_10_1186_s12887_019_1878_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-12-16 |
PublicationDateYYYYMMDD | 2019-12-16 |
PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-16 day: 16 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC pediatrics |
PublicationTitleAlternate | BMC Pediatr |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | AP Streissguth (1878_CR3) 2000; 5 J Pei (1878_CR13) 2011; 20 L Burd (1878_CR36) 2003; 25 MJ O'Connor (1878_CR12) 2009; 15 VJ Felitti (1878_CR29) 1998; 14 JD Stinson (1878_CR18) 2014; 7 JA Martin (1878_CR8) 2015; 64 L Burd (1878_CR22) 2016; 387 K Flannigan (1878_CR21) 2018; 57 SR Dube (1878_CR42) 2003; 37 IJ Chasnoff (1878_CR9) 2015; 135 CH Tan (1878_CR1) 2015; 64 EL Abel (1878_CR45) 1998 PA May (1878_CR7) 2015; 155 L Burd (1878_CR11) 2007; 6 C O'Leary (1878_CR14) 2013; 55 JJ Boseck (1878_CR15) 2015; 4 1878_CR17 S Lange (1878_CR37) 2013; 132 L Burd (1878_CR38) 2003; 25 JL Cook (1878_CR6) 2016; 188 M Schwartz (1878_CR25) 2017; 13 JR Greenmyer (1878_CR26) 2018; 12 A Thompson (1878_CR23) 2014; 4 L Burd (1878_CR27) 2013; 2 RAS Mukherjee (1878_CR35) 2019; 76 DJ Frankenberger (1878_CR33) 2015; 25 L Burd (1878_CR39) 2010; 44 H Nathan (1878_CR19) 2016; 3 L Burd (1878_CR24) 2004; 9 K McLachlan (1878_CR34) 2015; 22 D Weyrauch (1878_CR16) 2017; 38 CD Coles (1878_CR44) 2016; 40 DM Holman (1878_CR31) 2016; 138 S Popova (1878_CR43) 2016; 387 L Burd (1878_CR28) 2016; 387 1878_CR41 SR Dube (1878_CR30) 2009; 71 1878_CR4 Sean Johnson (1878_CR40) 2018; 39 1878_CR5 RF Anda (1878_CR32) 2007; 32 1878_CR2 B Sood (1878_CR10) 2001; 108 1878_CR20 |
References_xml | – volume: 57 start-page: 42 year: 2018 ident: 1878_CR21 publication-title: Int J Law Psychiatry doi: 10.1016/j.ijlp.2017.12.008 – volume: 12 start-page: 466 issue: 6 year: 2018 ident: 1878_CR26 publication-title: J Addict Med doi: 10.1097/ADM.0000000000000438 – volume: 37 start-page: 268 issue: 3 year: 2003 ident: 1878_CR42 publication-title: Prev Med doi: 10.1016/S0091-7435(03)00123-3 – volume: 38 start-page: 283 issue: 4 year: 2017 ident: 1878_CR16 publication-title: J Dev Behav Pediatr doi: 10.1097/DBP.0000000000000440 – volume: 7 start-page: 337 issue: 4 year: 2014 ident: 1878_CR18 publication-title: J Ment Health Res Intellect Disabil doi: 10.1080/19315864.2014.930549 – ident: 1878_CR4 – volume: 40 start-page: 1000 issue: 5 year: 2016 ident: 1878_CR44 publication-title: Alcohol Clin Exp Res doi: 10.1111/acer.13032 – ident: 1878_CR5 doi: 10.1176/appi.books.9780890425596 – volume: 64 start-page: 1 issue: 1 year: 2015 ident: 1878_CR8 publication-title: Natl Vital Stat Rep – ident: 1878_CR20 – volume: 138 start-page: S81 issue: Suppl 1 year: 2016 ident: 1878_CR31 publication-title: Pediatr doi: 10.1542/peds.2015-4268L – volume: 387 start-page: 926 issue: 10022 year: 2016 ident: 1878_CR28 publication-title: Lancet doi: 10.1016/S0140-6736(15)01346-X – volume: 44 start-page: 605 year: 2010 ident: 1878_CR39 publication-title: Alcohol doi: 10.1016/j.alcohol.2009.08.010 – volume: 55 start-page: 271 issue: 3 year: 2013 ident: 1878_CR14 publication-title: Dev Med Child Neurol doi: 10.1111/dmcn.12029 – volume: 32 start-page: 389 issue: 5 year: 2007 ident: 1878_CR32 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2007.01.005 – volume: 25 start-page: 688 issue: 6 year: 2015 ident: 1878_CR33 publication-title: Womens Health Issues doi: 10.1016/j.whi.2015.06.007 – volume: 135 start-page: 264 issue: 2 year: 2015 ident: 1878_CR9 publication-title: Pediatr doi: 10.1542/peds.2014-2171 – volume: 387 start-page: 926 issue: 10022 year: 2016 ident: 1878_CR22 publication-title: Lancet doi: 10.1016/S0140-6736(15)01346-X – volume: 25 start-page: 697 issue: 6 year: 2003 ident: 1878_CR36 publication-title: Neurotoxicol Teratol doi: 10.1016/j.ntt.2003.07.014 – volume: 132 start-page: e980 issue: 4 year: 2013 ident: 1878_CR37 publication-title: Pediatr doi: 10.1542/peds.2013-0066 – volume: 5 start-page: 177 issue: 3 year: 2000 ident: 1878_CR3 publication-title: Semin Clin Neuropsychiatry doi: 10.1053/scnp.2000.6729 – volume: 14 start-page: 245 issue: 4 year: 1998 ident: 1878_CR29 publication-title: Am J Prev Med doi: 10.1016/S0749-3797(98)00017-8 – volume: 22 start-page: e108 issue: 1 year: 2015 ident: 1878_CR34 publication-title: J Popul Ther Clin Pharmacol – ident: 1878_CR17 doi: 10.1111/add.14598 – volume: 25 start-page: 719 issue: 6 year: 2003 ident: 1878_CR38 publication-title: Neurotoxicol Teratol doi: 10.1016/j.ntt.2003.07.015 – ident: 1878_CR41 – volume: 64 start-page: 1042 issue: 37 year: 2015 ident: 1878_CR1 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6437a3 – volume: 188 start-page: 191 issue: 3 year: 2016 ident: 1878_CR6 publication-title: CMAJ doi: 10.1503/cmaj.141593 – volume: 108 start-page: E34 issue: 2 year: 2001 ident: 1878_CR10 publication-title: Pediatr doi: 10.1542/peds.108.2.e34 – volume: 13 start-page: 96 issue: 2 year: 2017 ident: 1878_CR25 publication-title: Curr Womens Health Rev doi: 10.2174/1573404813666170418114243 – volume: 9 start-page: 179 issue: 2 year: 2004 ident: 1878_CR24 publication-title: Addict Biol doi: 10.1080/13556210410001717088 – volume: 4 start-page: 21 year: 2014 ident: 1878_CR23 publication-title: Open J Pediatr doi: 10.4236/ojped.2014.41003 – volume: 71 start-page: 243 issue: 2 year: 2009 ident: 1878_CR30 publication-title: Psychosom Med doi: 10.1097/PSY.0b013e3181907888 – volume: 20 start-page: 438 issue: 5 year: 2011 ident: 1878_CR13 publication-title: J Ment Health doi: 10.3109/09638237.2011.577113 – ident: 1878_CR2 – volume: 155 start-page: 118 year: 2015 ident: 1878_CR7 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2015.08.006 – volume: 39 start-page: 163 issue: 2 year: 2018 ident: 1878_CR40 publication-title: Journal of Developmental & Behavioral Pediatrics doi: 10.1097/DBP.0000000000000523 – volume: 387 start-page: 978 issue: 10022 year: 2016 ident: 1878_CR43 publication-title: Lancet doi: 10.1016/S0140-6736(15)01345-8 – volume: 6 start-page: 383 issue: 4 year: 2007 ident: 1878_CR11 publication-title: Int J Disabil Hum Dev doi: 10.1515/IJDHD.2007.6.4.383 – volume: 15 start-page: 225 issue: 3 year: 2009 ident: 1878_CR12 publication-title: Dev Disabil Res Rev doi: 10.1002/ddrr.74 – volume-title: Fetal alcohol abuse syndrome year: 1998 ident: 1878_CR45 doi: 10.1007/978-1-4757-5217-5 – volume: 4 start-page: 230 issue: 4 year: 2015 ident: 1878_CR15 publication-title: Appl Neuropsychol Child doi: 10.1080/21622965.2013.877392 – volume: 3 start-page: 1214213 issue: 1 year: 2016 ident: 1878_CR19 publication-title: Cogent Psychol doi: 10.1080/23311908.2016.1214213 – volume: 2 start-page: 3 issue: 3 year: 2013 ident: 1878_CR27 publication-title: Int J Alcohol Drug Res doi: 10.7895/ijadr.v2i3.173 – volume: 76 start-page: 23 year: 2019 ident: 1878_CR35 publication-title: Alcohol doi: 10.1016/j.alcohol.2018.06.002 |
SSID | ssj0017846 |
Score | 2.4907143 |
Snippet | Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD... Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals... Abstract Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders.... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 498 |
SubjectTerms | Adolescent Adverse childhood experiences Adverse Childhood Experiences - statistics & numerical data Alcohol use Attention deficit hyperactivity disorder Child Child protection Child, Preschool Childhood Children Comorbidity Criminal justice Cross-Sectional Studies Disabilities Female Fetal Alcohol Spectrum Disorders Fetal alcohol syndrome Humans Hyperactivity Male Mental disorders Neurodevelopmental disorders Neurodevelopmental Disorders - epidemiology Neurodevelopmental Disorders - etiology Prevalence Self Report Sleep Sleep disorders Special education Womens health Young Adult |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9UwEA6yD-KLuF6rq0YQvEDYpm2S5vF4OSyCvujCvoXcigvaI3b3z-yvdSbJqS2CvvhSOM30NjOZy8nkG0Ket3XjnBCKIbw361xnmdYuMEidXeu8b-CA1Raf5Mlp9-FMnC1afWFNWIYHzow7FuBCfaMUBP6qCx3XetCDlC7Ug1A-JiRQ8Hn7ZKqsHyhwq2UNk_fyeAIr3GOJpWa8h7SpX3mhBNb_p0le-KR1veTCAW1vkZslcqSb_MaH5Focb5PrH8va-B1yteA03Q3UYqvlKVK_By-mcYY1nqgdA01YluF31RDcPRQwzomejzRXl1P8q5YOEYdtbqhL0_7Mn5ffF_Qvt5vP717l--5Ghr9oqYOf7pLT7fsvb09Y6bzAvND8gtna20bZ2EJ8IAapXK1b3XqpsZdVUB7kC25dNpoPjuuAvTNC2wzR2yhV5K69Rw7gWfEBoRIxIIWIwUFwKJ3rg0WMMzH4oBWEExWp95IwvsCSY3eMbyalJ700WXgGhGdQeKavyOv5kh8Zk-NvxG9QvDMhwmmnE6BkpiiZ-ZeSVeQpKofJe1Nno2A2Eru0QUQHn_EiUaBZgNf3tuxuACYgwNaK8mhFCdPZr4f3CmiKOZkMhL099uKpZUWezcN4JZbIjXF3mWgUguXXuiL3s77OHw2GG9JMriqiVpq84sp6ZDz_msDGpYaIsJMP_wcbH5EbTZqDDePyiByAosbHENNduCdp-v4CC-ZIkw priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3q2uGkHwAmGbtkmaJxkvwyLoiy7MW8it64K263b3z_hrPSfNdKcI-zIwk9NOm3NPTr5DyKu6rJwTQjGE92aNayzT2gUGqbOrnfcVfGC1xTd5eNR82YhNXnAbc1nl1iYmQx0Gj2vkB-D5W2xHUsr3p38Ydo3C3dXcQuM6uYHQZVjSpTZzwsUVONe8k8lbeTCCLW6x0FIz3kLy1C58UYLs_98w73imZdXkjhta3yG3c_xIVxPD75Jrsb9Hbn7NO-T3yd-d-aZDRy02XB4j9VsIYxpncOOR2j7QhGgZLmuH4O4hQ3KO9KSnU405xQVb2kUctlNbXZpOaZ5d_N6hf7Neff_0drrv0DP8RnM1_PiAHK0___h4yHL_BeaF5ufMlt5WysYaogTRSeVKXevaS40drYLywGVw7rLSvHNcB-ygEeqqi95GqSJ39UOyB_8VHxMqEQlSiBgchIjSuTZYRDoTnQ9aQVBRkHLLCeMzODn2yPhlUpLSSjMxzwDzDDLPtAV5N19yOiFzXEX8Adk7EyKodvphODs2WUeNgGjNV0pBjqma0HCtO91J6ULZCeVjU5AXKBxmOqE6mwazktirDeI6eI3XiQKNAzy-t_mMA0wCwmwtKPcXlKDUfjm8FUCTjcpoLlWgIC_nYbwSC-X6OFwkGoWQ-aUuyKNJXueXBvMNySZXBVELSV7MynKkP_mZIMelhriwkU-ufqyn5FaVtKtiXO6TPRDB-AxitnP3PCnmP3vrQNw priority: 102 providerName: ProQuest |
Title | Association of adverse childhood experiences and neurodevelopmental disorders in people with fetal alcohol spectrum disorders (FASD) and non-FASD controls |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31842817 https://www.proquest.com/docview/2328515506 https://www.proquest.com/docview/2327935509 https://pubmed.ncbi.nlm.nih.gov/PMC6912946 https://doaj.org/article/5639c27714474d4199f9f66bd0f57ce4 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9NAEB_uAcd9Ed9Gz7qC4AOiee5mP4i0euUQ7pDTQvHLkn1ED85UmzvQf8W_1plNmjZ4-MEvgXZn02ZnZmc2O_v7ATxJo0TrPBchwXuHmc7KUEptQ1w661Qbk-CFqi1O-NEsez_P51uworfqBrC5cmlHfFKz5fnLnz9-vUGHf-0dvuCvGpxjCyqglGFc4KKo2IZdDEyC_PQ4W28qCIy13cbmld32YQ8tHPNxz162jlIezP_vKXsjZg3rKTcC1PQ6XOsySzZuTeEGbLn6Juwdd3vnt-D3hibYomIlUTE3jpkVuDFzPexxw8raMo91addVRXh324F1NuysZm31OaNXuaxy1Fy2hLvMn99cXn7bkH82HX9897y976IO6RPr6uSb2zCbHn56exR2zAyhyWV8EZaRKRNRuhTzh7ziQkcylanhkriurDCofwz7PJFxpWNpiVvDpknlTOm4cLFO78AO_pa7B4wTRmSeO6sxeeRaF7YkDLS8MlYKTDcCiFaaUKaDLSf2jHPlly8FV60eFepRkR5VEcCLvsv3FrPjX8ITUm8vSHDb_ovF8ovqvFflmMeZRAhcfYrMZrGUlaw41zaqcmFcFsAjMg7Vnl3tJw015sTihhkfPsZTL0GGjH_flN3pBxwEAuAaSB4MJNHdzbB5ZYBq5S0K0-KCuHoiHsDjvpl6Ugld7RaXXkYQmH4kA7jb2mv_0CuzD0AMLHkwKsOW-uyrByPnEjPGjN__754PYD_xPpiEMT-AHbRO9xATvQs9gm0xFyPYnRyefDgd-dclI-_SeD2dfP4Dow1V0Q |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9RAFJ7gkqgvxrtVlDHRqCQTep3pPBizCJtFYGMUEt7GzqVAol2kEONf8Uf4Gz2nnZZtTHjjZZPdOe1Oe07PpXPm-wh5lYSx1lkmGMJ7s1SnBZNSWwals060MTF8YLfFjE8P0k-H2eES-dvthcG2ys4nNo7azg2-I1-HyJ8jHUnIP5z-ZMgahaurHYVGaxY77vcvKNnq99uboN_XcTzZ2v84ZZ5VgJlMRuesCE0Ri8IlEPuykgsNNb1MDJfI02SFgblDyOKxjEodSYu8EDaJS2cKx4WLdALnvUGW0wRKmRFZ3tiaff7Sr1sICOd-7TTK-XoN3j_H1k7JohzKtXwQ_RqSgP9DwUIsHPZpLgS-yV1yx2esdNya2D2y5Kr75OaeX5N_QP4saJjOS1ogxXPtqOlAk6nr4ZRrWlSWNhia9rJbCc5uPQhoTU8q2na1U3xFTEuHw0VL5EubfaFnFz8W5N9Oxl8337XnnVcMv1Hff18_JAfXoptHZAT_5Z4QyhF7Msuc1ZCUcq1zWyC2WlYaKwWkMQEJO00o4-HQkZXju2rKopyrVnkKlKdQeSoPyFp_yGmLBXKV8AaqtxdEGO_mh_nZkfJeQWWQH5pYCKhqRWrTSMpSlpxrG5aZMC4NyCoah2r3xPbOSI05ssNBJgmX8aaRQHcE0zeF31UBNwGBvQaSKwNJcCNmONwZoPJurFaXD11AXvbDeCS25lVuftHICATpD2VAHrf22l80BAwobyMREDGw5MFdGY5UJ8cNyDmXkImm_OnV01olt6b7e7tqd3u284zcjpsnLWYRXyEjMEf3HDLGc_3CP6aUfLtuz_APWBN-aw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+adverse+childhood+experiences+and+neurodevelopmental+disorders+in+people+with+fetal+alcohol+spectrum+disorders+%28FASD%29+and+non-FASD+controls&rft.jtitle=BMC+pediatrics&rft.au=Kambeitz%2C+Cassondra&rft.au=Klug%2C+Marilyn+G.&rft.au=Greenmyer%2C+Jacob&rft.au=Popova%2C+Svetlana&rft.date=2019-12-16&rft.pub=BioMed+Central&rft.eissn=1471-2431&rft.volume=19&rft_id=info:doi/10.1186%2Fs12887-019-1878-8&rft_id=info%3Apmid%2F31842817&rft.externalDocID=PMC6912946 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2431&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2431&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2431&client=summon |